PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pediatric Endocrinology, Rainbow Children\'s Hospital, Hyderabad, India.\', \'Division of Endocrinology, Boston Children\'s Hospital, Boston, Massachusetts, USA.\', \'New England Diabetes and Endocrinology Center, Waltham, Massachusetts, USA.\', \'Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria.\', \'Institute of Maternal and Child Research, School of Medicine, University of Chile, Santiago, Chile.\', \'Sydney Children\'s Hospital Network, Sydney, New South Wales, Australia.\', \'Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.\', \'School of Women\'s and Children\'s Health, University of New South Wales, Sydney, New South Wales, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/pedi.13118
?:hasPublicationType
?:journal
  • Pediatric diabetes
is ?:pmid of
?:pmid
?:pmid
  • 32935435
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.741
?:rankingScore_hIndex
  • 59
is ?:relation_isRelatedTo_publication of
?:title
  • ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all